EVAXION BIOTECH A S - ADS (EVAX)

CUSIP: 29970R105

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / ADS
Total 13F shares
1,077,414
Share change
+737,132
Total reported value
$4,763,000
Put/Call ratio
9%
Price per share
$4.42
Number of holders
11
Value change
+$1,884,508
Number of buys
11
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 29970R105?
CUSIP 29970R105 identifies EVAX - EVAXION BIOTECH A S - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVAXION BIOTECH A S - ADS (EVAX) as of Q4 2021

As of 31 Dec 2021, EVAXION BIOTECH A S - ADS (EVAX) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,077,414 shares. The largest 10 holders included LUMINUS MANAGEMENT LLC, Telemetry Investments, L.L.C., TWO SIGMA INVESTMENTS, LP, Kepos Capital LP, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, ETF MANAGERS GROUP, LLC, MORGAN STANLEY, UBS Group AG, and Steward Partners Investment Advisory, LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.